Detalhe da pesquisa
1.
Characterization of human antiviral adaptive immune responses during hepatotropic virus infection in HLA-transgenic human immune system mice.
J Immunol
; 191(4): 1753-64, 2013 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-23833235
2.
11ß-HSD1 inhibition reduces atherosclerosis in mice by altering proinflammatory gene expression in the vasculature.
Physiol Genomics
; 45(1): 47-57, 2013 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-23170035
3.
Complement regulates conventional DC-mediated NK-cell activation by inducing TGF-ß1 in Gr-1+ myeloid cells.
Eur J Immunol
; 42(7): 1723-34, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22535677
4.
Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.
Arthritis Rheum
; 63(9): 2764-73, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21560114
5.
11beta-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice.
J Exp Med
; 202(4): 517-27, 2005 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16103409
6.
Characterization of the NOD/scid-[Tg]DR1 mouse expressing HLA-DRB1*01 transgene: a model of SCID-hu mouse for vaccine development.
Exp Hematol
; 35(8): 1219-30, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17662890
7.
Interferon-α and angiogenic dysregulation in pregnant lupus patients who develop preeclampsia.
Arthritis Rheumatol
; 67(4): 977-87, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25603823
8.
Use of humanized severe combined immunodeficient mice for human vaccine development.
Expert Rev Vaccines
; 8(1): 113-20, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19093778
9.
Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.
Bioorg Med Chem Lett
; 15(23): 5266-9, 2005 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16185866
10.
Potent Kv1.3 inhibitors from correolide-modification of the C18 position.
Bioorg Med Chem Lett
; 15(2): 447-51, 2005 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-15603971
11.
Immunosuppressive effects of a Kv1.3 inhibitor.
Cell Immunol
; 221(2): 100-6, 2003 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-12747950
12.
Intra-thymic/splenic engraftment of human T cells in HLA-DR1 transgenic NOD/scid mice.
Cell Immunol
; 232(1-2): 86-95, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15922719
13.
N-isonicotinoyl-(L)-4-aminophenylalanine derivatives as tight binding VLA-4 antagonists.
Bioorg Med Chem Lett
; 13(11): 1891-5, 2003 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-12749892
14.
A small molecule very late antigen-4 antagonist can inhibit ovalbumin-induced lung inflammation.
Am J Respir Crit Care Med
; 167(10): 1400-9, 2003 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12569079
15.
Benzamide derivatives as blockers of Kv1.3 ion channel.
Bioorg Med Chem Lett
; 13(6): 1161-4, 2003 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-12643934
16.
Potent S1P receptor agonists replicate the pharmacologic actions of the novel immune modulator FTY720.
Bioorg Med Chem Lett
; 14(12): 3351-5, 2004 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-15149705